SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-256922
Filing Date
2023-10-16
Accepted
2023-10-16 16:37:27
Documents
2
Group Members
CHEN YUTCG CROSSOVER FUND I, L.P.TCG CROSSOVER FUND II, L.P.TCG CROSSOVER GP I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d733041dsc13g.htm SC 13G 105778
2 EX-99.1 d733041dex991.htm EX-99.1 6603
  Complete submission text file 0001193125-23-256922.txt   114182
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Subject) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-86249 | Film No.: 231327700
SIC: 2834 Pharmaceutical Preparations

Mailing Address 705 HIGH STREET PALO ALTO CA 94301
Business Address 705 HIGH STREET PALO ALTO CA 94301 650-924-9424
TCG Crossover GP II, LLC (Filed by) CIK: 0001969280 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G